The global pharmaceutical industry 1. Identify the main environmental forces currently affecting the global pharmaceutical industry. The PESTEL analysis can be used to identify the main environmental forces for the industry: Political • Stringent government regulation and powerful purchaser pressures. • Governments around the world focused on pharmaceuticals as a politically easy target in efforts to control rising healthcare expenditure. • Inter-country pricing disparities. Economic
Premium Pharmaceutical industry Generic drug Food and Drug Administration
Ethics in the Pharmaceutical Industry The pharmaceutical industry started in the middle Ages‚ 18th AD in Baghdad in 754 by an Arabian. Until the early 70’s the industry grew at a small pace. In the 1970’s business began to boom and competition began to upsurge. In the 1990’s these industries and companies became more aggressive with their marketing strategies. In ’97 the U.S. Food and Drug Administration brought new rules and regulations concerning the marketing area and it required companies to
Premium Pharmacology Marketing Sales
Ethics in pharmaceutical marketing xxxxx EMBA 1.1/Academic Skills Subject Outline December 23rd‚ 2012 Prof. xxxxx Ethics and pharmaceutical marketing The pharmaceutical industry has been facing challenges with respect to ethical marketing and promotional practices. The conflict of commercial interests with adherence to ethical practices has been a subject of much deliberation. While such debates tend to have a high degree of subjective and emotive content‚ it is also a concern
Premium Marketing Corporate social responsibility Business ethics
API PRESENTATTION Some Definitions- Active Pharmaceutical Ingredient (API): A substance or compound that is intended to be used in the manufacture of a pharmaceutical product as a therapeutically active compound (ingredient) Enantiomers: cpds with same molecular formula as substance but differ in spatial arrangement of atoms and are non-superimpossable mirror images Polymorphism: Occurrence of different crystalline forms of the same substance Degradation product : Molecule resulting
Premium Pharmacology Chemistry Pharmaceutical drug
use of plants has been central to medicine since the beginning of time and it remains important today. Discuss the drug development and characterization problems with using plant extracts as therapeutic agents. How are plants used today by the pharmaceutical industry? Use specific product examples in your answer. The use of plants has played an important role in medicine. The traditional herbal medicine‚ typically the Chinese herbal medicine‚ primarily relies on the use of a mixture
Premium Pharmacology Pharmaceutical drug
Pharmaceutical Pricing Strategy Ryan Ritchey American Military University November 22‚ 2009 Pharmaceutical companies are in constant pricing competition and innovative “idea wars” so to speak. Differential pricing‚ the specific price structuring and implementation‚ is the solution to resolving the conflict between pharmaceutical drug patents. There are always several different brands of drugs that can be prescribed or even bought over-the-counter‚ but the decision of the consumer or medical
Premium Pharmacology Pricing Generic drug
Supply and Demand Pharmaceutical Industry In today ’s society‚ a large percentage of the population requires prescription drugs to treat injury or illness. In some cases‚ the need for drugs may be short term and in other cases‚ the drugs may be required for the remainder of an individual ’s life. In all cases‚ prescription drugs are not free; the individual or his or her insurance company pays. The type of drug and available substitutions generally drive the costs. In this paper‚ I will summarize
Premium Pharmacology Pharmaceutical industry Food and Drug Administration
1. What kind of multiproduct strategy is Novartis following? Explain. Novartis acquisition in eye care company Alcon Inc. is an example of Related Diversification Multiproduct Strategy due to the fact that Novartis and Alcon both perform their business in health care industry. In addition‚ Novartis prescription drug make up 60% of the total sales indicate that company is operating in moderate to high level of diversification. The acquisition of Alcon Inc. establishes a related link between
Premium Novartis Pharmaceutical industry
Global Pharmaceutical Industry Analysis September 21 2009 Dibakar Mitra (P08017) I Manoj Joshi (B08026) Table of Contents EXECUTIVE SUMMARY 3 INTRODUCTION 4 ORIGIN AND EVOLUTION 5 ENVIRONMENT ANALYSIS (PEST) 7 STRUCTURAL INDUSTRY ANALYSIS (PORTER) 8 STRATEGIC ISSUES FACING THE INDUSTRY 11 STRATEGIC GROUPS IN THE INDUSTRY ACCORDING TO MARKET/DRUG/FUNCTIONING 15 PROCESS FLOW: IMPORTANT FUNCTIONS 16 STRATEGIC RESPONSES TO CHALLENGES: SIMPLE CORRELATION BETWEEN GROUP
Premium Pharmaceutical industry
Introduction: Square Pharmaceuticals Ltd. (SPL) has been the trendsetter in Bangladesh Pharmaceutical Market since its inception in 1958. Over the last decade SPL actually rose to a new standard moving beyond manufacturing quality medicines to win mindshare of patients‚ physicians‚ shareholders‚ business partners‚ and communities where we work and live. Our dedication to add more value to the common wealth of the society compounded by innovative strategies for
Premium Pharmacology Pharmaceutical industry Pharmaceutical drug